| Symbol | AMIX |
|---|---|
| Name | AUTONOMIX MEDICAL, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical/Dental Instruments |
| Address | 21 WATERWAY AVENUE,SUITE 300, THE WOODLANDS, Texas, 77380, United States |
| Telephone | +1 713 - 588-6150 |
| Fax | — |
| — | |
| Website | https://www.autonomix.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001617867 |
| Description | Autonomix, were developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. This opens us up to a world of possibilities in the field of electrophysiology. Clinical trials start this year for the treatment of pancreatic cancer pain and pancreatitis pain. Additional info from NASDAQ: |
Director KLEMP WALTER V 🟢 acquired 13.0K shares of Autonomix Medical, Inc. (AMIX) Transaction Date: Sep 03, 2026 | Filing ID: 029835
Read moreDirector Bisson Lori 🟢 acquired 13.0K shares of Autonomix Medical, Inc. (AMIX) Transaction Date: Sep 03, 2026 | Filing ID: 029833
Read moreHauser Bradley 🟢 acquired 27.0K shares of Autonomix Medical, Inc. (AMIX) Transaction Date: Sep 03, 2026 | Filing ID: 029830
Read moreNew Form PRE 14A - Autonomix Medical, Inc. <b>Filed:</b> 2026-09-04 <b>AccNo:</b> 0001437749-26-029716 <b>Size:</b> 949 KB
Read moreNew Form S-3 - Autonomix Medical, Inc. <b>Filed:</b> 2026-09-04 <b>AccNo:</b> 0001437749-26-029712 <b>Size:</b> 527 KB
Read moreAutonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026
Read moreAutonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery
Read moreAutonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery
Read moreAutonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules
Read moreAutonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission
Read more